WO2006120568A3 - Composition pharmaceutique comprenant un agent antiparasitaire , et un actif choisi parmi le carveol , le thymol , l ugenol , le borneol , le carvacrol , l lpha- ionone ou le beta-ionone - Google Patents
Composition pharmaceutique comprenant un agent antiparasitaire , et un actif choisi parmi le carveol , le thymol , l ugenol , le borneol , le carvacrol , l lpha- ionone ou le beta-ionone Download PDFInfo
- Publication number
- WO2006120568A3 WO2006120568A3 PCT/IB2006/001441 IB2006001441W WO2006120568A3 WO 2006120568 A3 WO2006120568 A3 WO 2006120568A3 IB 2006001441 W IB2006001441 W IB 2006001441W WO 2006120568 A3 WO2006120568 A3 WO 2006120568A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- ionone
- carveol
- carvacrol
- borneol
- thymol
- Prior art date
Links
- BAVONGHXFVOKBV-UHFFFAOYSA-N Carveol Chemical compound CC(=C)C1CC=C(C)C(O)C1 BAVONGHXFVOKBV-UHFFFAOYSA-N 0.000 title abstract 4
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 title abstract 4
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 title abstract 4
- PSQYTAPXSHCGMF-BQYQJAHWSA-N β-ionone Chemical compound CC(=O)\C=C\C1=C(C)CCCC1(C)C PSQYTAPXSHCGMF-BQYQJAHWSA-N 0.000 title abstract 4
- SFEOKXHPFMOVRM-UHFFFAOYSA-N (+)-(S)-gamma-ionone Natural products CC(=O)C=CC1C(=C)CCCC1(C)C SFEOKXHPFMOVRM-UHFFFAOYSA-N 0.000 title abstract 2
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 title abstract 2
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 title abstract 2
- BAVONGHXFVOKBV-ZJUUUORDSA-N (-)-trans-carveol Natural products CC(=C)[C@@H]1CC=C(C)[C@@H](O)C1 BAVONGHXFVOKBV-ZJUUUORDSA-N 0.000 title abstract 2
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 title abstract 2
- 239000005770 Eugenol Substances 0.000 title abstract 2
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 title abstract 2
- 239000005844 Thymol Substances 0.000 title abstract 2
- UZFLPKAIBPNNCA-UHFFFAOYSA-N alpha-ionone Natural products CC(=O)C=CC1C(C)=CCCC1(C)C UZFLPKAIBPNNCA-UHFFFAOYSA-N 0.000 title abstract 2
- UZFLPKAIBPNNCA-BQYQJAHWSA-N alpha-ionone Chemical compound CC(=O)\C=C\C1C(C)=CCCC1(C)C UZFLPKAIBPNNCA-BQYQJAHWSA-N 0.000 title abstract 2
- 239000003096 antiparasitic agent Substances 0.000 title abstract 2
- 229940125687 antiparasitic agent Drugs 0.000 title abstract 2
- 229940116229 borneol Drugs 0.000 title abstract 2
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 title abstract 2
- RECUKUPTGUEGMW-UHFFFAOYSA-N carvacrol Chemical compound CC(C)C1=CC=C(C)C(O)=C1 RECUKUPTGUEGMW-UHFFFAOYSA-N 0.000 title abstract 2
- HHTWOMMSBMNRKP-UHFFFAOYSA-N carvacrol Natural products CC(=C)C1=CC=C(C)C(O)=C1 HHTWOMMSBMNRKP-UHFFFAOYSA-N 0.000 title abstract 2
- 235000007746 carvacrol Nutrition 0.000 title abstract 2
- 229930007646 carveol Natural products 0.000 title abstract 2
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 title abstract 2
- 229960002217 eugenol Drugs 0.000 title abstract 2
- WYXXLXHHWYNKJF-UHFFFAOYSA-N isocarvacrol Natural products CC(C)C1=CC=C(O)C(C)=C1 WYXXLXHHWYNKJF-UHFFFAOYSA-N 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 229960000790 thymol Drugs 0.000 title abstract 2
- 239000004480 active ingredient Substances 0.000 title 1
- 239000000126 substance Substances 0.000 abstract 2
- 230000001225 therapeutic effect Effects 0.000 abstract 2
- 239000003430 antimalarial agent Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Priority Applications (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AP2007004228A AP2437A (en) | 2005-05-13 | 2006-05-15 | Pharmaceutical composition containing an anti parasitic agent and an active ingredient selected fromcarveol, thymol, eugenol, borneol, carvacrol, alpha-ionone, or beta-ionone |
DK06755932.8T DK1883452T3 (da) | 2005-05-13 | 2006-05-15 | Farmaceutisk sammensætning indeholdende et anti-parasitmiddel og et aktivstof valgt fra thymol, eugenol eller carvacrol |
CN2006800161609A CN101175532B (zh) | 2005-05-13 | 2006-05-15 | 包含一种抗寄生虫药物和一种选自香芹醇、麝香草酚、丁香酚、樟醇、香芹酚、α-紫罗兰酮或β-紫罗兰酮的活性成分的药物组合物 |
EP06755932A EP1883452B1 (fr) | 2005-05-13 | 2006-05-15 | Composition pharmaceutique comprenant un agent antiparasitaire et un actif choisi parmi le thymol, l'eugénol, et le carvacrol |
US11/914,019 US20080171768A1 (en) | 2005-05-13 | 2006-05-15 | Pharmaceutical Composition Containing An Anti Parasitic Agent And Active Ingredient Selected From Carveol, Thymol, Eugenol, Borneol, Carvacrol, Alpha-Ionone, Or Beta-Ionone |
BRPI0610130-5A BRPI0610130A2 (pt) | 2005-05-13 | 2006-05-15 | composição farmacêutica, kit e utilização de uma composição |
CA2606887A CA2606887C (fr) | 2005-05-13 | 2006-05-15 | Composition pharmaceutique |
ES06755932T ES2399348T3 (es) | 2005-05-13 | 2006-05-15 | Composición farmacéutica que comprende un agente antiparasitario y una sustancia activa elegida entre timol, eugenol y carvacrol |
TNP2007000423A TNSN07423A1 (fr) | 2005-05-13 | 2007-11-13 | Composition pharmaceutique comprenant un agent antiparasitaire, et un actif choisi parmi le carveol, le thymol, l'eugenol, le borneol, le carvacrol, l 'alpha-ionone ou le beta-ionone |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/IB2005/001314 WO2006120495A1 (fr) | 2005-05-13 | 2005-05-13 | Composition pharmaceutique comprenant un antiviral, an antitumoral ou un antiparasitaire, et un actif choisi parmi le carveol, le thymol, l’eugenol, le borneol et le carvacrol |
IBPCT/IB2005/001314 | 2005-05-13 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2006120568A2 WO2006120568A2 (fr) | 2006-11-16 |
WO2006120568A3 true WO2006120568A3 (fr) | 2007-08-23 |
Family
ID=35427309
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2005/001314 WO2006120495A1 (fr) | 2005-05-13 | 2005-05-13 | Composition pharmaceutique comprenant un antiviral, an antitumoral ou un antiparasitaire, et un actif choisi parmi le carveol, le thymol, l’eugenol, le borneol et le carvacrol |
PCT/IB2006/001441 WO2006120568A2 (fr) | 2005-05-13 | 2006-05-15 | Composition pharmaceutique comprenant un agent antiparasitaire , et un actif choisi parmi le carveol , le thymol , l ugenol , le borneol , le carvacrol , l lpha- ionone ou le beta-ionone |
PCT/IB2006/001328 WO2006120564A1 (fr) | 2005-05-13 | 2006-05-15 | Composition pharmaceutique comprenant un antiviral , un antitumoral ou un antiparasitaire, et un actif choisi parmi le carveol , le thymol, l' eugenol, le borneol et le carvacrol |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2005/001314 WO2006120495A1 (fr) | 2005-05-13 | 2005-05-13 | Composition pharmaceutique comprenant un antiviral, an antitumoral ou un antiparasitaire, et un actif choisi parmi le carveol, le thymol, l’eugenol, le borneol et le carvacrol |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2006/001328 WO2006120564A1 (fr) | 2005-05-13 | 2006-05-15 | Composition pharmaceutique comprenant un antiviral , un antitumoral ou un antiparasitaire, et un actif choisi parmi le carveol , le thymol, l' eugenol, le borneol et le carvacrol |
Country Status (16)
Country | Link |
---|---|
US (2) | US20080171768A1 (fr) |
EP (2) | EP1879656B1 (fr) |
JP (1) | JP5073651B2 (fr) |
CN (2) | CN101193682B (fr) |
AP (1) | AP2437A (fr) |
AT (1) | ATE554827T1 (fr) |
BR (2) | BRPI0610123A2 (fr) |
CA (2) | CA2606887C (fr) |
DK (2) | DK1879656T3 (fr) |
EA (1) | EA015168B1 (fr) |
ES (2) | ES2386292T3 (fr) |
MA (2) | MA29908B1 (fr) |
PT (2) | PT1883452E (fr) |
TN (2) | TNSN07423A1 (fr) |
WO (3) | WO2006120495A1 (fr) |
ZA (1) | ZA200710785B (fr) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080113042A1 (en) * | 2006-09-05 | 2008-05-15 | Chu Kee Hung | Pharmaceutical composition and method for cancer treatment based on combinational use of conventional anticancer agents and geranium oil or compounds thereof |
US20080293648A1 (en) * | 2007-01-05 | 2008-11-27 | Saha Pharmaceuticals, Inc. | Compositions and Methods for Cancer Treatment |
BRPI1009199A2 (pt) | 2009-03-17 | 2016-03-08 | Concert Pharmaceuticals Inc | compostos de pirazinoisoquinolina |
PL2480090T3 (pl) | 2009-09-24 | 2014-04-30 | Unilever Nv | Środek dezynfekujący zawierający eugenol, terpineol oraz tymol |
CN103354741B (zh) | 2010-12-07 | 2016-01-13 | 荷兰联合利华有限公司 | 口腔护理组合物 |
EP2773315B1 (fr) | 2011-11-03 | 2015-07-08 | Unilever N.V. | Composition pour hygiène personnelle |
CN102579449B (zh) * | 2012-03-30 | 2013-08-07 | 厦门大学 | 一种可提高肿瘤对紫杉醇敏感性的联合用药 |
GB201404505D0 (en) * | 2013-09-06 | 2014-04-30 | Mars Inc | Oral anti-parasitic composition |
KR20170052626A (ko) | 2014-09-05 | 2017-05-12 | 심바이오믹스 세러퓨틱스 엘엘씨 | 세균질증 치료에 사용하기 위한 세크니다졸 |
WO2016153078A1 (fr) * | 2015-03-20 | 2016-09-29 | Opiyo Sammy Oyoo | Utilisation de suramine et d'inhibiteurs de l'arginase dans une néoplasie maligne |
CA2988082C (fr) | 2015-06-01 | 2020-09-29 | Symbiomix Therapeutics, Llc | Nouvelles formulations de nitroimidazole et leurs utilisations |
CN105147647A (zh) * | 2015-08-19 | 2015-12-16 | 华南理工大学 | 右旋龙脑作为抗肿瘤药物增敏剂的应用 |
MA44286A (fr) | 2016-06-02 | 2019-01-09 | Advanced Scient Developements | Formulation pharmaceutique de cinéol et d'amoxicilline |
WO2018176079A1 (fr) * | 2017-03-28 | 2018-10-04 | Iriccorgpharm Pty Ltd | Alcaloïdes berbérine dans la prévention et/ou le traitement d'une maladie intestinale |
CN112972437B (zh) * | 2021-02-19 | 2022-03-25 | 沈阳伟嘉生物技术有限公司 | 一种包含碘硝酚的长效外用制剂及其制备方法和用途 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996040192A1 (fr) * | 1995-06-07 | 1996-12-19 | Avmax, Inc. | Utilisation d'huiles essentielles pour accroitre la biodisponibilite des composes pharmaceutiques oraux |
WO1997035839A1 (fr) * | 1995-03-08 | 1997-10-02 | Schering Aktiengesellschaft | Nouveaux borneols, leur procede de fabrication et leur utilisation pharmaceutique |
WO2001058486A2 (fr) * | 2000-02-14 | 2001-08-16 | Kleine & Steube Entoxin Gmbh | Compositions a effet immunoregulateur, procedes permettant de les preparer et leur utilisation |
US20030064948A1 (en) * | 2001-02-08 | 2003-04-03 | Alfred Fahr | Invasomes for therapy of disorders, their preparation and use |
WO2003069993A1 (fr) * | 2002-02-20 | 2003-08-28 | Pharmessen Scientific, Inc. | Compositions therapeutiques antimicrobiennes et modes d'utilisation |
US20030225003A1 (en) * | 2002-04-18 | 2003-12-04 | Dusan Ninkov | Antimicrobial therapeutic compositions for oral and topical use |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3634697A1 (de) * | 1986-10-11 | 1988-04-21 | Dentaire Ivoclar Ets | Dentalwerkstoff zur bekaempfung von karies und parodontose |
WO2000033857A1 (fr) * | 1998-12-07 | 2000-06-15 | Ecosmart Technologies, Inc. | Composition anticancereuse et procede d'utilisation d'huiles essentielles vegetales naturelles |
US6536268B1 (en) * | 1999-11-01 | 2003-03-25 | Siemens Vdo Automotive Corporation | Utilizing increasing width for identification voltages |
AU2002227913B2 (en) * | 2000-11-09 | 2007-08-02 | Jorg P. Schur | Synergistic medicament containing aromatic agents and having an antagonistic, regenerative and/or protagonist decontamination effect |
US20040092583A1 (en) * | 2001-01-02 | 2004-05-13 | Elizabeth Shanahan-Prendergast | Treatment for inhibiting neoplastic lesions |
EA200500804A1 (ru) * | 2002-12-10 | 2005-12-29 | Биосинексус Инкорпорейтед | Топические противоинфекционные композиции |
US20040151771A1 (en) * | 2003-02-04 | 2004-08-05 | Gin Jerry B. | Long-lasting, flavored dosage forms for sustained release of beneficial agents within the mouth |
CN100343223C (zh) * | 2005-03-07 | 2007-10-17 | 常州市智能动物药业有限公司 | 百里酚或香芹酚的酯类化合物、制备方法及其药物活性组合物 |
-
2005
- 2005-05-13 WO PCT/IB2005/001314 patent/WO2006120495A1/fr active Application Filing
-
2006
- 2006-05-15 EA EA200702486A patent/EA015168B1/ru not_active IP Right Cessation
- 2006-05-15 CN CN2006800203654A patent/CN101193682B/zh not_active Expired - Fee Related
- 2006-05-15 PT PT67559328T patent/PT1883452E/pt unknown
- 2006-05-15 US US11/914,019 patent/US20080171768A1/en not_active Abandoned
- 2006-05-15 ES ES06744739T patent/ES2386292T3/es active Active
- 2006-05-15 ES ES06755932T patent/ES2399348T3/es active Active
- 2006-05-15 DK DK06744739.1T patent/DK1879656T3/da active
- 2006-05-15 CA CA2606887A patent/CA2606887C/fr not_active Expired - Fee Related
- 2006-05-15 CA CA2608061A patent/CA2608061C/fr not_active Expired - Fee Related
- 2006-05-15 BR BRPI0610123-2A patent/BRPI0610123A2/pt not_active Application Discontinuation
- 2006-05-15 CN CN2006800161609A patent/CN101175532B/zh not_active Expired - Fee Related
- 2006-05-15 DK DK06755932.8T patent/DK1883452T3/da active
- 2006-05-15 WO PCT/IB2006/001441 patent/WO2006120568A2/fr active Application Filing
- 2006-05-15 EP EP06744739A patent/EP1879656B1/fr active Active
- 2006-05-15 BR BRPI0610130-5A patent/BRPI0610130A2/pt not_active Application Discontinuation
- 2006-05-15 AT AT06744739T patent/ATE554827T1/de active
- 2006-05-15 US US11/914,029 patent/US20080171709A1/en not_active Abandoned
- 2006-05-15 JP JP2008510669A patent/JP5073651B2/ja not_active Expired - Fee Related
- 2006-05-15 WO PCT/IB2006/001328 patent/WO2006120564A1/fr active Application Filing
- 2006-05-15 PT PT06744739T patent/PT1879656E/pt unknown
- 2006-05-15 AP AP2007004228A patent/AP2437A/xx active
- 2006-05-15 EP EP06755932A patent/EP1883452B1/fr active Active
-
2007
- 2007-11-13 TN TNP2007000423A patent/TNSN07423A1/fr unknown
- 2007-11-13 TN TNP2007000426A patent/TNSN07426A1/fr unknown
- 2007-12-12 ZA ZA200710785A patent/ZA200710785B/xx unknown
- 2007-12-28 MA MA30531A patent/MA29908B1/fr unknown
- 2007-12-28 MA MA30528A patent/MA29573B1/fr unknown
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997035839A1 (fr) * | 1995-03-08 | 1997-10-02 | Schering Aktiengesellschaft | Nouveaux borneols, leur procede de fabrication et leur utilisation pharmaceutique |
WO1996040192A1 (fr) * | 1995-06-07 | 1996-12-19 | Avmax, Inc. | Utilisation d'huiles essentielles pour accroitre la biodisponibilite des composes pharmaceutiques oraux |
WO2001058486A2 (fr) * | 2000-02-14 | 2001-08-16 | Kleine & Steube Entoxin Gmbh | Compositions a effet immunoregulateur, procedes permettant de les preparer et leur utilisation |
US20030064948A1 (en) * | 2001-02-08 | 2003-04-03 | Alfred Fahr | Invasomes for therapy of disorders, their preparation and use |
WO2003069993A1 (fr) * | 2002-02-20 | 2003-08-28 | Pharmessen Scientific, Inc. | Compositions therapeutiques antimicrobiennes et modes d'utilisation |
US20030225003A1 (en) * | 2002-04-18 | 2003-12-04 | Dusan Ninkov | Antimicrobial therapeutic compositions for oral and topical use |
Non-Patent Citations (2)
Title |
---|
BAILENGER, J. ET AL: "A new anthelmintic : piperazine thymolsulfonate . I. Experimental study", BULLETIN DES TRAVAUX DE LA SOCIETE DE PHARMACIE DE BORDEAUX , 93, 161-6 CODEN: BTSPA9; ISSN: 0366-3825, 1955, XP008079770 * |
OELKERS, H. A.: "The mechanism of the anthelmintic action of piperazine", ARZNEIMITTEL-FORSCH. , 7, 329-30, 1957, XP008079795 * |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2006120568A3 (fr) | Composition pharmaceutique comprenant un agent antiparasitaire , et un actif choisi parmi le carveol , le thymol , l ugenol , le borneol , le carvacrol , l lpha- ionone ou le beta-ionone | |
WO2006120567A3 (fr) | Combinaison pharmaceutique comprenant un antibacterien et une substance active choisie parmi le carveol, le thymol, l'eugenol, le borneol et le carvacrol | |
EA200702482A1 (ru) | Фармацевтическая композиция, содержащая противогрибковый агент и активный ингредиент, выбранный из карвеола, тимола, эвгенола и карвакрола | |
WO2007119098A3 (fr) | Procédés destinés au traitement des acouphènes déclenchés par une excitotoxicité cochléaire | |
AP2405A (en) | Cannabinoid active pharmaceutical ingredient for improved dosage forms. | |
WO2004016277A3 (fr) | Ameliorations apportees a l'extraction de composants pharmaceutiquement actifs issus de vegetaux | |
IL195269A0 (en) | Pharmaceutical formulations for the sustained release of active ingredient(s), as well as their applications, especially therapeutic | |
WO2005117895A3 (fr) | Compositions contenant de la meloxicame | |
MA30504B1 (fr) | Compositions pharmaceutiques stabilisees comprenant de la fesoterodine | |
WO2007014124A3 (fr) | Formes posologiques et preparations a charge medicamenteuse elevee | |
WO2007095043A3 (fr) | Formulations pharmaceutiques | |
WO2004073632A3 (fr) | Formulations d'agonistes 5-ht selectifs a absorption rapide | |
WO2007090661A3 (fr) | Combinaison de substances actives | |
WO2007092469A3 (fr) | Combinaison de composes organiques | |
WO2007009691A3 (fr) | Combinaison de substances active s | |
WO2007011958A3 (fr) | Formes posologiques intra-buccales de glucagon | |
EP1584335A3 (fr) | Combinaison de substances actives comprenant un composé carbinol et un opioïde | |
WO2008004100A9 (fr) | Composés thérapeutiques | |
WO2007065625A3 (fr) | Compositions pharmaceutiques a base d'agents hypnotiques de courte duree d’action, disponibles sous formes a liberation modifiee, et procedes de preparation desdites formulations | |
WO2006039268A3 (fr) | Formulations pharmaceutiques renfermant des molecules tpgs de vitamine e solubilisant des medicaments lipophiles sans inhibition importante de l'ecoulement et utilisation de telles formulations | |
WO2005097192A3 (fr) | Combinaison de substances actives | |
WO2006138431A3 (fr) | Procedes et preparations pharmaceutiques pour l'accroissement de la biodisponibilite | |
WO2008111296A1 (fr) | Agent pharmaceutique pour la prévention et le traitement d'une maladie cutanée induite par une kératinisation accélérée | |
WO2007022532A3 (fr) | Composes cyclopropyles et compositions permettant de liberer des agents actifs | |
WO2008058938A3 (fr) | Millepertuis et dérivés de millepertuis constituant des potentialisateurs d'analgésique |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2006755932 Country of ref document: EP Ref document number: 2606887 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: AP/P/2007/004228 Country of ref document: AP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 200680016160.9 Country of ref document: CN |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 8781/DELNP/2007 Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: DZP2007000783 Country of ref document: DZ |
|
NENP | Non-entry into the national phase |
Ref country code: RU |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: RU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 11914019 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 2006755932 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: PI0610130 Country of ref document: BR Kind code of ref document: A2 Effective date: 20071113 |